Bizmoon
Grants & Loans
Regulations
Industries
Sign in
Learn more
Bizmoon

Product

  • Grants
  • Regulations
  • License checker
  • Guides
  • How it works
  • Pricing
  • Blog

Industries

  • Healthcare
  • Trade and Commerce
  • Transportation and Logistics
  • Energy and Utilities
  • Finance and Banking
  • Land and Natural Resources
  • Agriculture

Coverage

  • All grants
  • All regulations
  • Federal grants
  • Federal regulations

Company

  • Careers
  • Sign in
© 2026 BizmoonPrivacyTermsCredits
  1. Home
  2. Regulations
  3. Federal
  4. Page 22

Federal regulations

Agency
  • SEC223
  • HHS215
  • DOC204
  • DOT204
  • FDA188
  • DOE156
  • DHS146
FERC
138
  • FAA107
  • EPA87
  • DOJ71
  • NOAA66
  • USDA64
  • Treasury62
  • NIH54
  • DOL47
  • SBA29
  • FCC28
  • HUD20
  • CMS18
  • IRS15
  • FTC4
  • Recency
    • Last 30 days
    • Last 7 days
    HHSRemove filter: HHSClear all
    • Center for Scientific Review; Notice of Closed Meetings
      June 8, 2026

      Center for Scientific Review will hold closed meetings to review grant applications and discuss personnel matters; meeting dates and locations available upon request to authorized participants.

    • Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Meeting
      June 8, 2026

      The Eunice Kennedy Shriver National Institute of Child Health & Human Development will hold a public meeting to discuss research priorities and funding opportunities for small businesses in maternal and child health sectors.

    • Proposed Information Collection Activity; ACF-700 Tribal Annual Report
      June 8, 2026

      ACF-700 Tribal Annual Report to OMB requests reinstatement with revisions designed to reduce annual burden hours for tribal reporting under OMB #0970-0430.

    • Office of the Director, National Institutes of Health; Notice of Meeting
      June 8, 2026

      National Institutes of Health Director's office will hold a public meeting to discuss agency policy and research priorities.

    • Determination That Protamine Sulfate (Protamine Sulfate) Intravenous; Solution, 50 Milligrams/5 Milliliters, and Other Drug Products Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness
      June 8, 2026

      FDA determines protamine sulfate intravenous solution (50 mg/5 mL) and related drug products were not withdrawn for safety or effectiveness reasons, permitting continued ANDA approvals for equivalent formulations.

    PreviousPage 22 of 22 (215 total)

    Track Federal regulations for your business

    Tell Bizmoon what your business does and we'll cut the Federal Register down to what actually matters.

    Action items + deadlines

    Every rule is broken into specific to-dos with calendar dates.

    Affected areas

    We tell you which parts of your business each rule actually touches.

    Plain-English summaries

    Healthcare draws more federal rulemaking than any other sector

    After healthcare come the capital-heavy sectors: trade, transportation, energy, and finance. If you operate in one of them, the volume of change is relentless.

    Federal rulemaking

    • Healthcare and life sciences
    • Trade and commerce
    • Transportation and aviation
    • Energy and utilities
    • Finance
    • Natural resources
    • Other

    Browse by agency

    • CMS
    • DHS
    • DOC
    • DOE
    • DOJ
    • DOL

    Browse by state

    • Arizona
    • California
    • Colorado
    • Florida
    • Illinois
    • Kentucky

    No legal jargon. Read the impact in two sentences.

    Real-time alerts

    Email + dashboard pings the moment something changes.

    Get started free
  • DOT
  • EPA
  • FAA
  • FCC
  • FDA
  • FERC
  • FTC
  • HHS
  • HUD
  • IRS
  • NIH
  • NOAA
  • SBA
  • SEC
  • Treasury
  • USDA
  • Maryland
  • Massachusetts
  • Michigan
  • Minnesota
  • Missouri
  • New York
  • North Carolina
  • Ohio
  • Pennsylvania
  • South Carolina
  • Tennessee
  • Texas
  • Virginia
  • Washington
  • Wisconsin
  • Federal grants